Tag: takeda pharmaceuticals

August 27, 2019

Adaptimmune and Noile-Immune to Develop SPEAR T-Cell Products

The companies anticipate that they will be able to receive approval for first human testing as early as 2021.
July 16, 2019

Biotech Market Update: Q2 2019 in Review

With Q2 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...
December 24, 2018

Pharma Outlook 2019: Drug Pricing Dialogue Continues

During this challenging time in healthcare news, our pharma outlook aims to help investors steer through the industry.
December 13, 2018

Pharma Trends 2018: Drug Pricing Takes Center Stage

Knowing what pharma trends influenced the market this year may be key for new and ongoing investing opportunities.
November 1, 2018

Denali Therapeutics Partners with Sanofi

The companies will jointly develop RIPK1 inhibitor molecules, which could treat Alzheimer’s disease, amyotrophic lateral sclerosis, multiple sclerosis and more.